BionetworkConsulting

Digital Health & SaMD Regulatory Enablement

The Growing Importance of Digital Health & SaMD

Digital health technologies are transforming patient care, diagnostics, and disease management. From mobile medical applications and digital therapeutics to AI-driven clinical decision support tools, Software as a Medical Device (SaMD) is reshaping how healthcare is delivered. However, innovation in digital health must be matched with robust regulatory, quality, and validation strategies. Regulatory agencies now expect digital health companies to demonstrate the same rigor in safety, effectiveness, data integrity, and lifecycle management as traditional medical products.

Digital health application used in regulated healthcare environment

Regulatory Landscape for Digital Health Technologies

Digital health and SaMD products must navigate a complex and evolving regulatory environment, including:

  • FDA SaMD and Digital Health guidance

  • EU MDR and IVDR requirements

  • IMDRF SaMD framework

  • 21 CFR Part 11 and Annex 11 for electronic records

  • Cybersecurity and data privacy expectations

Misinterpreting regulatory pathways or delaying compliance planning can result in approval delays, rework, or enforcement actions. BioNetwork Consulting helps you navigate this complexity with clarity and confidence.

Our Approach to Digital Health & SaMD Enablement

BioNetwork Consulting provides end-to-end regulatory enablement for digital health and SaMD products across the full lifecycle. Our approach includes:

  1. Regulatory Pathway Assessment: Determine classification, submission type, and global strategy

  2. Quality & Compliance Frameworks: Establish scalable QMS aligned with digital product development

  3. Software Validation & CSV: Ensure systems meet GxP and FDA expectations

  4. Risk Management: Apply ISO 14971 and SaMD-specific risk methodologies

  5. Lifecycle Governance: Manage updates, AI model changes, and post-market obligations

This integrated approach accelerates market entry while minimizing compliance risk.

Software as a Medical Device SaMD user interface
FDA regulatory pathway for Software as a Medical Device

Key Benefits of Partnering with BioNetwork Consulting

  • Faster Market Access: Clear regulatory pathways and reduced rework

  • Regulatory Confidence: Alignment with FDA, EMA, and global expectations

  • Audit Readiness: Inspection-ready documentation and validated systems

  • Scalable Compliance: Frameworks that grow with your digital product

  • Cross-Functional Expertise: Regulatory, quality, CSV, and clinical insight in one partner

We support startups, scale-ups, and global enterprises bringing digital health innovations to market.

Digital Health & SaMD Services We Offer

Our comprehensive services include:

  • SaMD regulatory strategy and classification

  • FDA pre-submission and submission support

  • EU MDR and global regulatory planning

  • Software development lifecycle (SDLC) compliance

  • Computer System Validation (CSV) for SaMD platforms

  • Cybersecurity and data integrity support

  • Clinical evaluation and real-world evidence strategy

  • Post-market surveillance and change management

Digital health regulatory compliance and documentation review

Ensuring Compliance, Validation, and Audit Readiness

Digital health products face intense regulatory scrutiny due to rapid software changes and evolving AI capabilities. BioNetwork Consulting ensures:

  • Validation strategies aligned with agile development

  • Traceability between requirements, risks, and testing

  • Audit-ready documentation for inspections

  • Change control processes for software updates and AI models

  • Alignment with 21 CFR Part 11, GxP, and global standards

Our proactive approach reduces compliance risk throughout the product lifecycle.

Scroll to Top